{"entities":{"Q42318":{"pageid":32686,"ns":120,"title":"Item:Q42318","lastrevid":145222,"modified":"2026-08-13T08:46:22Z","type":"item","id":"Q42318","labels":{"mul":{"language":"mul","value":"BC43.7"},"pt-br":{"language":"pt-br","value":"Cardiomiopatia diab\u00e9tica"},"en":{"language":"en","value":"Diabetic cardiomyopathy"}},"descriptions":{"pt-br":{"language":"pt-br","value":"Cardiomiopatia diab\u00e9tica \u00e9 a presen\u00e7a de disfun\u00e7\u00e3o mioc\u00e1rdica na aus\u00eancia de doen\u00e7a arterial coronariana cl\u00ednica evidente, doen\u00e7a valvar e outros fatores de risco cardiovascular convencionais, como hipertens\u00e3o e dislipidemia. Caracteriza-se inicialmente por fibrose mioc\u00e1rdica, remodelamento disfuncional e disfun\u00e7\u00e3o diast\u00f3lica, evoluindo para disfun\u00e7\u00e3o sist\u00f3lica e insufici\u00eancia card\u00edaca. _x000D_ _x000D_ Informa\u00e7\u00f5es adicionais. O desenvolvimento e a progress\u00e3o de cardiomiopatia diab\u00e9tica t\u00eam sido associados ao comprometimento da sinaliza\u00e7\u00e3o metab\u00f3lica da insulina no cora\u00e7\u00e3o, aumento do estresse oxidativo, redu\u00e7\u00e3o da biodisponibilidade do \u00f3xido n\u00edtrico, rigidez da matriz extracelular e dos cardiomi\u00f3citos a base de col\u00e1geno, comprometimento do manuseio do c\u00e1lcio por mitoc\u00f4ndrias e cardiomi\u00f3citos, inflama\u00e7\u00e3o, ativa\u00e7\u00e3o do sistema renina-angiotensina-aldosterona, neuropatia auton\u00f4mica card\u00edaca, estresse do ret\u00edculo endoplasm\u00e1tico, disfun\u00e7\u00e3o microvascular e uma mir\u00edade de anormalidades metab\u00f3licas card\u00edacas."},"en":{"language":"en","value":"Diabetic cardiomyopathy is the presence of myocardial dysfunction in the absence of overt clinical coronary artery disease, valvar disease, and other conventional cardiovascular risk factors, such as hypertension and dyslipidemia. It is initially characterised by myocardial fibrosis, dysfunctional remodeling, and diastolic dysfunction, progressing to systolic dysfunction and heart failure. Additional information. The development and progression of diabetic cardiomyopathy has been linked to impaired cardiac insulin metabolic signaling, increases in oxidative stress, reduced nitric oxide bioavailability, collagen-based cardiomyocyte and extracellular matrix stiffness, impaired mitochondrial and cardiomyocyte calcium handling, inflammation, renin\u2013angiotensin\u2013aldosterone system activation, cardiac autonomic neuropathy, endoplasmic reticulum stress, microvascular dysfunction, and a myriad of cardiac metabolic abnormalities."}},"aliases":{},"claims":{"P68":[{"mainsnak":{"snaktype":"value","property":"P68","hash":"7872a4764c6a1326350f7c3c37ce8a1847000f5e","datavalue":{"value":"https://id.who.int/icd/entity/848543944","type":"string"},"datatype":"url"},"type":"statement","id":"Q42318$BC825FC0-83D0-4FD3-AF86-94BACF305B48","rank":"normal"}],"P67":[{"mainsnak":{"snaktype":"value","property":"P67","hash":"a603e27fccbc14a50f925b3e1f5ead73fadea588","datavalue":{"value":"CID11:BC43.7","type":"string"},"datatype":"string"},"type":"statement","id":"Q42318$D9BCB63E-14A3-44C1-BF17-8219E4FF3798","rank":"normal"}],"P70":[{"mainsnak":{"snaktype":"value","property":"P70","hash":"035bae444bb100e8bafbfd582b37b18f121d6a5b","datavalue":{"value":"dki-india-BC43.7","type":"string"},"datatype":"string"},"type":"statement","id":"Q42318$2B2917AC-5C5D-4594-A65B-BD0FA0A09E69","rank":"normal"}],"P86":[{"mainsnak":{"snaktype":"value","property":"P86","hash":"a96031634b9f5dafddaf781bbba3adea6bb64ef4","datavalue":{"value":"Conclu\u00eddo","type":"string"},"datatype":"string"},"type":"statement","id":"Q42318$35E226BA-9107-4E65-B4AC-B26B1B33686D","rank":"normal"}],"P78":[{"mainsnak":{"snaktype":"value","property":"P78","hash":"5f9b5be68b7400da549761cf15abfdbc4d1e075b","datavalue":{"value":"https://pauloleads.com.br/cases-publicos/","type":"string"},"datatype":"url"},"type":"statement","id":"Q42318$B5D15FA8-AA21-42C3-9243-DBAE54161112","rank":"normal"}],"P80":[{"mainsnak":{"snaktype":"value","property":"P80","hash":"92b8222fcbb75718504f915073a3f43bd4003d18","datavalue":{"value":{"time":"+2026-08-13T00:00:00Z","timezone":0,"before":0,"after":0,"precision":11,"calendarmodel":"http://www.wikidata.org/entity/Q1985727"},"type":"time"},"datatype":"time"},"type":"statement","id":"Q42318$23164A32-70A4-465F-8137-CE2637641F83","rank":"normal"}],"P89":[{"mainsnak":{"snaktype":"value","property":"P89","hash":"d2448b26b6fdefb0db599c2d2722b469df60c83b","datavalue":{"value":{"entity-type":"item","numeric-id":42317,"id":"Q42317"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q42318$E9454207-3859-4867-9459-3CA526AD872F","rank":"normal"}]},"sitelinks":{}}}}